Literature DB >> 28290928

Indications of Recruitment Challenges in Research with U.S. Military Service Members: A ClinicalTrials.gov Review.

Wendy A Cook1, Ardith Z Doorenbos2.   

Abstract

INTRODUCTION: The success of military-relevant health research often depends on recruiting adequate numbers of U.S. military service members as research participants. Researchers have reported difficulties in recruiting service member research participants. Reviews of ClinicalTrials.gov, an online clinical trial registry of publicly and privately sponsored studies, have identified challenges in participant recruitment and barriers to study completion in various research populations. The purpose of this study was to identify indications of difficulty recruiting U.S. military service members as research participants based on data from study records in ClinicalTrials.gov.
MATERIALS AND METHODS: Records of studies starting between 2005 and 2014 were collected from ClinicalTrials.gov and updated through January 2016. Three hundred and two studies that included ≥25% U.S. military service member research participants were (1) compared to a comparison group of 302 studies, each with <5% service member participants and (2) compared by the proportion of service member participants within studies in the military group ("many" ≥25% but <100% service members and "all" 100% service members). Groups were evaluated and compared for recruitment status; reasons for study withdrawal, termination, or suspension; achievement of ≥85% of the anticipated enrollment; and differences in achieving recruitment goals according to study sponsor.
RESULTS: Twelve percent of studies in the military group had been withdrawn, terminated, or suspended; enrollment and funding problems were the most common reasons. The comparison group had 11% of studies withdrawn, terminated, or suspended; the most common reasons were enrollment problems and sponsor decision. All study groups had indications of difficulty adequately achieving participant enrollment goals. Among studies with known anticipated and actual enrollment, approximately half in both the military group (47.9%) and comparison group (50.3%) achieved ≥85% of the anticipated enrollment (p = 0.722). Half of studies with many service members and 44% of studies with all service members achieved ≥85% of the anticipated enrollment (p = 0.600). In comparing the many and all service member subgroups, significant differences were found in the median values for anticipated enrollment and actual enrollment, even when accounting for Bonferroni correction. Evaluations of mean values did not show a statistical difference between the military subgroups. There were no significant differences according to study sponsor (military, academic, Veterans Affairs, National Institutes of Health, nonprofit organization, or industry) for a study achieving or not achieving ≥85% of the anticipated enrollment.
CONCLUSION: This review supports anecdotal reports of difficulty recruiting service members as research participants. However, the findings also indicate that in many regards, there is not much difference in the difficulties recruiting service members versus other research participants. Findings suggest that it is often difficult to recruit research participants regardless of the specific population or type of study sponsor, and that studies with either many or all service member participants have similar achievement of recruitment goals. Findings in this study may be useful for those who design research that includes service members or for those who are apprehensive about including service members in their research. Reprint &
Copyright © 2017 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Year:  2017        PMID: 28290928      PMCID: PMC5540645          DOI: 10.7205/MILMED-D-16-00225

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  9 in total

Review 1.  Recruitment and attrition issues in military clinical trials and health research studies.

Authors:  Nigel E Bush; Sean C Sheppard; Emily Fantelli; Kathleen R Bell; Mark A Reger
Journal:  Mil Med       Date:  2013-11       Impact factor: 1.437

Review 2.  The need for reform of human subjects protections in military health research.

Authors:  Reg Arthur Williams; Gary Gatien; Bonnie M Hagerty
Journal:  Mil Med       Date:  2012-02       Impact factor: 1.437

3.  Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.

Authors:  Sabrina Bernardez-Pereira; Renato D Lopes; Maria Julia Machline Carrion; Eliana Vieira Santucci; Rafael Marques Soares; Matheus de Oliveira Abreu; Ligia Nasi Laranjeira; Dimas T Ikeoka; Ana Denise Zazula; Frederico Rafael Moreira; Alexandre Biasi Cavalcanti; Evandro Tinoco Mesquita; Eric D Peterson; Robert M Califf; Otavio Berwanger
Journal:  Am Heart J       Date:  2014-05-02       Impact factor: 4.749

4.  Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.

Authors:  Sara K Pasquali; Wendy K Lam; Karen Chiswell; Alex R Kemper; Jennifer S Li
Journal:  Pediatrics       Date:  2012-10-01       Impact factor: 7.124

5.  Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.

Authors:  Benjamin Carlisle; Jonathan Kimmelman; Tim Ramsay; Nathalie MacKinnon
Journal:  Clin Trials       Date:  2014-12-04       Impact factor: 2.486

6.  Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials.

Authors:  M Soledad Cepeda; Victor Lobanov; Jesse A Berlin
Journal:  J Pain       Date:  2013-02-28       Impact factor: 5.820

7.  Research on U.S. Military Women: Recruitment and Retention Challenges and Strategies.

Authors:  Lisa A Braun; Holly P Kennedy; Lois S Sadler; Jane Dixon
Journal:  Mil Med       Date:  2015-12       Impact factor: 1.437

8.  Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination.

Authors:  Rebecca J Williams; Tony Tse; Katelyn DiPiazza; Deborah A Zarin
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  Trends in Research with U.S. Military Service Member Participants: A Population-Specific ClinicalTrials.gov Review.

Authors:  Wendy A Cook; Ardith Z Doorenbos; Elizabeth J Bridges
Journal:  Contemp Clin Trials Commun       Date:  2016-04-30
  9 in total
  5 in total

1.  Lessons learned conducting a multi-center trial with a military population: The Tinnitus Retraining Therapy Trial.

Authors:  Roberta W Scherer; Leonora D Sensinger; Benigno Sierra-Irizarry; Craig Formby
Journal:  Clin Trials       Date:  2018-05-23       Impact factor: 2.486

2.  Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience.

Authors:  Vanita R Aroda; Patricia R Sheehan; Ellen M Vickery; Myrlene A Staten; Erin S LeBlanc; Lawrence S Phillips; Irwin G Brodsky; Chhavi Chadha; Ranee Chatterjee; Miranda G Ouellette; Cyrus Desouza; Anastassios G Pittas
Journal:  Clin Trials       Date:  2019-04-22       Impact factor: 2.486

3.  Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual.

Authors:  Grace Clarke Hillyer; Yeun-Hee Anna Park; Ta-Chueh Hsu Rosenberg; Prabhjot Mundi; Imtiaz Patel; Susan E Bates
Journal:  Semin Oncol       Date:  2021-05-03       Impact factor: 4.929

4.  Impact of financial reimbursement on retention rates in military clinical trial research: A natural experiment within a multi-site randomized effectiveness trial with active duty service members.

Authors:  Laura A Novak; Bradley E Belsher; Michael C Freed; Phoebe K McCutchan; Xian Liu; Daniel P Evatt; Terri Tanielian; Robert M Bray; Charles C Engel
Journal:  Contemp Clin Trials Commun       Date:  2019-04-13

5.  Obstacles to the reuse of study metadata in ClinicalTrials.gov.

Authors:  Laura Miron; Rafael S Gonçalves; Mark A Musen
Journal:  Sci Data       Date:  2020-12-18       Impact factor: 6.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.